Platelet-Rich Plasma (PRP) in IVF: Evidence and Applications
Definition and Preparation of PRP
- PRP is an autologous or allogeneic blood derivative containing a supraphysiological concentration of platelets that release growth factors and cytokines from α-granules to promote tissue healing 1
- PRP preparation methods vary widely, leading to inconsistent terminology, product characteristics, and clinical outcomes 2
- Clinical preparations of PRP are poorly standardized, with content, purity, and biological properties varying widely, which impacts clinical efficacy 2
Limitations and Safety Considerations
- The International Society on Thrombosis and Haemostasis emphasizes that autologous/allogeneic sterile PRP preparations are clinically safe, but proper sterile technique is essential during preparation and application 2
- Many trials fail to fully define the content, purity, and biological properties of platelet preparations, making it difficult to compare results across studies 2
Current Recommendations
- The American College of Medical Genetics and Genomics (ACMG) has not specifically addressed PRP use in IVF but emphasizes the need for practice guidelines before widespread implementation of any new reproductive technology 3
- The American College of Obstetricians and Gynecologists (ACOG) does not currently recommend routine use of similar adjunctive technologies like PGT-A for IVF in infertile women due to lack of proven efficacy 3
- Clinical trials on PRP in reproductive medicine should be adequately powered and controlled, with clear inclusion/exclusion criteria, standardized assessments, and objectively measured clinical endpoints 2